Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome:: A cross-sectional analytic study

被引:25
作者
Franciosi, Monica [1 ]
Pellegrini, Fabio [1 ]
Sacco, Michele [1 ]
De Berardis, Giorgia [1 ]
Rossi, Maria C. E. [1 ]
Strippoli, Giovanni F. M. [1 ]
Belfiglio, Maurizio [1 ]
Tognoni, Gianni [1 ]
Valentini, Miriam [1 ]
Nicolucci, Antonio [1 ]
机构
[1] Consorzio Mario Negri Sud, Dept Clin Pharmacol & Epidemiol, I-66030 Santa Maria Imbaro, CH, Italy
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2007年 / 2卷 / 05期
关键词
D O I
10.2215/CJN.01190307
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: The objective of this study was to investigate correlates of risk for having microalbuminuria in individuals with one or more cardiovascular risk factors. Design, setting, participants, & measurements: The study involved 1919 individuals who attended general practice settings, were aged 55 to 75 yr, and did not have a history of cardiovascular events or diabetes but had one or more cardiovascular risk factors. A tree-based regression technique and multivariate analysis were used to identify distinct, homogeneous subgroups of patients with different likelihood of having microalburninuria; interaction between correlates of microalbuminuria and risk for microalbuminuria was also investigated. Results: The prevalence of microalbuminuria was 5.9%. Patients who did not have hypertension and had postload glycemia < 140 mg/dl showed the lowest prevalence of microalbumirturia (1.9%) and represented the reference class. The likelihood of microalbuminuria was seven times higher in men with hypertension and homeostatic model assessment levels in the upper tertile and four times higher in women with the same characteristics. Individuals with hypertension and lower homeostatic model assessment levels and normotensive individuals with increased likelihood of having microalbuminuria. Treatment postload glycentia >= 140 mg/dI had a more than three-fold with statins was associated with a 54% reduction in the likelihood of having microalbuminuria, whereas levels of triglycerides > 150 mg/dl and fibrinogen levels in the upper tertile were associated with a significantly higher risk for microalbuminuria. Conclusions: The likelihood of having microalburninuria in a population-based study of elderly individuals is strongly related to the interaction between the components of the metabolic syndrome, particularly hypertension, insulin resistance, and impaired glucose tolerance.
引用
收藏
页码:984 / 991
页数:8
相关论文
共 34 条
  • [1] A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease
    Bianchi, S
    Bigazzi, R
    Caiazza, A
    Campese, VM
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (03) : 565 - 570
  • [2] Progression to overt nephropathy in type 2 diabetes - The Casale Monferrato study
    Bruno, G
    Merletti, F
    Biggeri, A
    Bargero, G
    Ferrero, S
    Pagano, G
    Perin, PC
    [J]. DIABETES CARE, 2003, 26 (07) : 2150 - 2155
  • [3] The metabolic syndrome and chronic kidney disease in US adults
    Chen, J
    Muntner, P
    Hamm, LL
    Jones, DW
    Batuman, V
    Fonseca, V
    Whelton, PK
    He, J
    [J]. ANNALS OF INTERNAL MEDICINE, 2004, 140 (03) : 167 - 174
  • [4] Ciampi A, 1992, P PRAG 1991 SUMM SCH, P105
  • [5] 3-hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway: Implications for diabetic nephropathy
    Danesh, FR
    Sadeghi, MM
    Amro, N
    Philips, C
    Zeng, LX
    Lin, S
    Sahai, A
    Kanwar, YS
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (12) : 8301 - 8305
  • [6] Insulin resistance precedes microalbuminuria in patients with insulin-dependent diabetes mellitus
    Ekstrand, AV
    Groop, PH
    Grönhagen-Riska, C
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (12) : 3079 - 3083
  • [7] Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance - The IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study
    Franciosi, M
    De Berardis, G
    Rossi, MCE
    Sacco, M
    Belfiglio, M
    Pellegrini, F
    Tognoni, G
    Valentini, M
    Nicolucci, A
    [J]. DIABETES CARE, 2005, 28 (05) : 1187 - 1194
  • [8] Insulin resistance precedes the appearance of albuminuria in non-diabetic subjects: 6 years follow up study
    Fujikawa, R
    Okubo, M
    Egusa, G
    Kohno, N
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2001, 53 (02) : 99 - 106
  • [9] Fibrinogen and von Willebrand factor in IDDM: Relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: The EURODIAB IDDM complications study
    Greaves, M
    Malia, RG
    Goodfellow, K
    Mattock, M
    Stevens, LK
    Stephenson, JM
    Fuller, JH
    Karamanos, B
    Tountas, C
    Kofinis, A
    Petrou, K
    Katsilambros, N
    Giorgino, R
    Cignarelli, M
    DeCicco, ML
    Ramunni, I
    IonescuTirgoviste, C
    Iosif, CM
    Pitei, D
    Buligescu, S
    Tamas, G
    Kerenyi, Z
    Ahmed, AM
    Toth, J
    Kempler, P
    Muntoni, S
    Songini, M
    Stabilini, M
    Fossarello, M
    Pintus, S
    Ferriss, JB
    Cronin, CC
    Whyte, AE
    Cleary, PE
    Toeller, M
    Klischan, A
    Forst, T
    Gries, FA
    Rottiers, R
    Priem, H
    Ebeling, P
    Sinisalo, M
    Koivisto, VA
    IdziorWalus, B
    Solnica, B
    SzopinskaCiba, L
    Solnica, K
    Krans, HMJ
    Lemkes, HHPJ
    Jansen, JJ
    [J]. DIABETOLOGIA, 1997, 40 (06) : 698 - 705
  • [10] INSULIN-RESISTANCE, HYPERTENSION AND MICROALBUMINURIA IN PATIENTS WITH TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS
    GROOP, L
    EKSTRAND, A
    FORSBLOM, C
    WIDEN, E
    GROOP, PH
    TEPPO, AM
    ERIKSSON, J
    [J]. DIABETOLOGIA, 1993, 36 (07) : 642 - 647